Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $835.75 | 19 | 49.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $700.00 | 1 | 41.3% |
| Education | $99.99 | 1 | 5.9% |
| Travel and Lodging | $57.16 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $700.00 | 1 | $0 (2017) |
| Pulmonx Corporation | $474.45 | 12 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2017) |
| Genentech USA, Inc. | $99.99 | 1 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $82.63 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $76.02 | 2 | $0 (2023) |
| Scilex Pharmaceuticals Inc. | $48.09 | 1 | $0 (2018) |
| Radius Health, Inc. | $35.00 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $31.46 | 1 | $0 (2024) |
| GENZYME CORPORATION | $20.26 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31.46 | 1 | GlaxoSmithKline, LLC. ($31.46) |
| 2023 | $248.44 | 4 | Pulmonx Corporation ($191.28) |
| 2022 | $20.26 | 1 | GENZYME CORPORATION ($20.26) |
| 2021 | $14.99 | 1 | Pulmonx Corporation ($14.99) |
| 2020 | $108.66 | 2 | Pulmonx Corporation ($108.66) |
| 2019 | $377.14 | 9 | Pulmonx Corporation ($159.52) |
| 2018 | $48.09 | 1 | Scilex Pharmaceuticals Inc. ($48.09) |
| 2017 | $843.86 | 3 | PFIZER INC. ($700.00) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $31.46 | General |
| Category: IMMUNOLOGY | ||||||
| 09/29/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Travel and Lodging | Cash or cash equivalent | $57.16 | General |
| Category: Respiratory | ||||||
| 02/17/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, PULMONX CHARTIS TABLET CONSOLE | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: PULMONOLOGY | ||||||
| 01/30/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $98.67 | General |
| Category: PULMONOLOGY | ||||||
| 01/24/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $66.67 | General |
| Category: PULMONOLOGY | ||||||
| 10/17/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Immunology | ||||||
| 08/08/2021 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: PULMONOLOGY | ||||||
| 11/19/2020 | Pulmonx Corporation | Pulmonx Endobronchial Valve EBV (Device) | Food and Beverage | Cash or cash equivalent | $63.22 | General |
| Category: Pulmonology | ||||||
| 10/08/2020 | Pulmonx Corporation | Pulmonx Endobronchial Valve EBV (Device) | Food and Beverage | Cash or cash equivalent | $45.44 | General |
| Category: Pulmonology | ||||||
| 12/13/2019 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $82.63 | General |
| 11/10/2019 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Endocrinology | ||||||
| 08/20/2019 | Pulmonx Corporation | Pulmonx Endobronchial Valve EBV (Device) | Food and Beverage | Cash or cash equivalent | $54.28 | General |
| Category: Pulmonology | ||||||
| 07/17/2019 | Pulmonx Corporation | Pulmonx Endobronchial Valve EBV (Device) | Food and Beverage | Cash or cash equivalent | $37.78 | General |
| Category: Pulmonology | ||||||
| 06/17/2019 | Pulmonx Corporation | Pulmonx Endobronchial Valve EBV (Device) | Food and Beverage | Cash or cash equivalent | $23.37 | General |
| Category: Pulmonology | ||||||
| 06/04/2019 | Pulmonx Corporation | Pulmonx Endobronchial Valve EBV (Device) | Food and Beverage | Cash or cash equivalent | $20.67 | General |
| Category: Pulmonology | ||||||
| 05/19/2019 | Genentech USA, Inc. | Esbriet (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 04/05/2019 | Pulmonx Corporation | Pulmonx Endobronchial Valve EBV (Device) | Food and Beverage | Cash or cash equivalent | $18.77 | General |
| Category: Pulmonology | ||||||
| 04/04/2019 | Pulmonx Corporation | Pulmonx Endobronchial Valve EBV (Device) | Food and Beverage | Cash or cash equivalent | $4.65 | General |
| Category: Pulmonology | ||||||
| 12/08/2018 | Scilex Pharmaceuticals Inc. | ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) | Food and Beverage | In-kind items and services | $48.09 | General |
| Category: Analgesic | ||||||
| 09/30/2017 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | Cash or cash equivalent | $18.86 | General |
| 05/21/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 04/10/2017 | PFIZER INC. | VFEND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $700.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 141 | 142 | $5,958 | $1,313 |
| 2022 | 11 | 305 | 425 | $66,771 | $18,481 |
| 2021 | 10 | 353 | 534 | $92,519 | $26,665 |
| 2020 | 6 | 176 | 335 | $97,675 | $25,688 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 60 | 61 | $2,440 | $420.29 | 17.2% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 19 | 19 | $1,558 | $354.54 | 22.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 24 | 24 | $720.00 | $241.44 | 33.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 26 | 26 | $520.00 | $193.44 | 37.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 12 | 12 | $720.00 | $103.32 | 14.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 114 | $28,500 | $10,076 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 32 | 44 | $17,600 | $3,527 | 20.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 23 | $3,910 | $1,381 | 35.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $2,760 | $948.31 | 34.4% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 27 | 28 | $2,296 | $542.35 | 23.6% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 58 | 66 | $2,640 | $452.34 | 17.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 41 | 41 | $1,230 | $429.14 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 14 | 17 | $4,675 | $409.10 | 8.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 41 | 41 | $820.00 | $317.81 | 38.8% |
| 94375 | Test to measure rate of airflow | Facility | 2022 | 17 | 17 | $1,020 | $200.91 | 19.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 22 | 22 | $1,320 | $197.08 | 14.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 52 | 130 | $32,500 | $11,492 | 35.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 43 | 102 | $17,340 | $6,313 | 36.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 25 | 37 | $14,800 | $2,786 | 18.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 30 | 55 | $15,125 | $2,626 | 17.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 18 | 20 | $4,600 | $1,558 | 33.9% |
| 94618 | Test for exercise-induced lung stress | Facility | 2021 | 26 | 27 | $2,214 | $526.77 | 23.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 61 | 65 | $2,680 | $468.00 | 17.5% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 41 | 41 | $1,330 | $430.91 | 32.4% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 40 | 40 | $910.00 | $311.60 | 34.2% |
About Dr. Richard Barbers, M.D
Dr. Richard Barbers, M.D is a Pulmonary Disease healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194754572.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Barbers, M.D has received a total of $1,693 in payments from pharmaceutical and medical device companies, with $31.46 received in 2024. These payments were reported across 22 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($835.75).
As a Medicare-enrolled provider, Barbers has provided services to 975 Medicare beneficiaries, totaling 1,436 services with total Medicare billing of $72,147. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Los Angeles, CA
- Active Since 06/30/2006
- Last Updated 11/27/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1194754572
Products in Payments
- VFEND (Drug) $700.00
- Pulmonx Endobronchial Valve EBV (Device) $268.18
- CHARTIS CATHETER (Device) $206.27
- Esbriet (Biological) $99.99
- FASENRA (Biological) $57.16
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $48.09
- Tymlos (Biological) $35.00
- NUCALA (Biological) $31.46
- DUPIXENT (Biological) $20.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Los Angeles
Prof. Toby Maher, Md, MD
Pulmonary Disease — Payments: $1.1M
Donald Tashkin, Md, MD
Pulmonary Disease — Payments: $646,650
Rajan Saggar, Md, MD
Pulmonary Disease — Payments: $426,392
John Belperio, Md, MD
Pulmonary Disease — Payments: $308,808
Christopher Cooper, Md, MD
Pulmonary Disease — Payments: $207,817
Robert Strieter, Md, MD
Pulmonary Disease — Payments: $172,942